Lastly, further prospective studies would be needed to compare negative inotropic drugs with myosin inhibitors, specifically in the subset of obstructive HCM patients with atrial fibrillation, as mavacamten does not exert any classic antiarrhythmic effect. Here, MYH14 is linked to atrial fibrillation.